{"id":21393,"date":"2022-08-09T08:51:05","date_gmt":"2022-08-09T08:51:05","guid":{"rendered":"https:\/\/haberulus.net\/?p=21393"},"modified":"2022-08-09T08:51:05","modified_gmt":"2022-08-09T08:51:05","slug":"biontech-omicron-asisi-ne-zaman-cikacak-hangi-varyantlara-etkili","status":"publish","type":"post","link":"https:\/\/haberulus.net\/?p=21393","title":{"rendered":"BioNTech omicron a\u015f\u0131s\u0131 ne zaman \u00e7\u0131kacak, hangi varyantlara etkili?"},"content":{"rendered":"<p><b>D\u00fcnya genelinde yayg\u0131n bir varyant haline gelen omicron i\u00e7in Biontech a\u015f\u0131 \u00fcretimine haz\u0131rlan\u0131yor. Omicron BA.4 ve BA.5 gibi yeni Covid-19 varyantlar\u0131na kar\u015f\u0131 geli\u015ftirilen a\u015f\u0131n\u0131n Ekim ay\u0131nda teslim da\u011f\u0131t\u0131ma \u00e7\u0131kabilece\u011fi duyuruldu. <\/b><\/p>\n<p>\u0130lkbahar aylar\u0131nda d\u00fc\u015fen vaka say\u0131s\u0131n\u0131n yaz aylar\u0131nda tekrar y\u00fckseli\u015fe ge\u00e7mesinin ard\u0131ndan vir\u00fcse kar\u015f\u0131 etkili olacak a\u015f\u0131lar vatanda\u015flar\u0131n merak konusu oldu. Yeni a\u015f\u0131 BioNTech ve Pfizer\u2019\u0131n Omicron\u2019un BA.4 ve BA.5 varyantlar\u0131na kar\u015f\u0131 koruma sa\u011flayacak.<\/p>\n<p><strong>B\u0130ONTECH OM\u0130CRON A\u015eISI NE ZAMAN \u00c7IKACAK?<\/strong><\/p>\n<p>A\u00e7\u0131klama, \u00d6zlem T\u00fcreci ile U\u011fur \u015eahin&#8217;in Almanya&#8217;da kurdu\u011fu BioNTech&#8217;ten geldi. \u015eirket \u201cUzun ve geni\u015f bir koruma\u201d sa\u011flamak i\u00e7in geli\u015ftirilen Covid-19 a\u015f\u0131s\u0131n\u0131n g\u00fcncel versiyonu i\u00e7in klinik testlere ba\u015fland\u0131\u011f\u0131n\u0131 duyurdu.<\/p>\n<p>BioNTech taraf\u0131ndan yap\u0131lan a\u00e7\u0131klamada yeni a\u015f\u0131n\u0131n Omicron BA.4 ve BA.5 gibi yeni Covid-19 varyantlar\u0131na kar\u015f\u0131 geli\u015ftirildi\u011fine vurgu yap\u0131ld\u0131. Bu ay i\u00e7inde yeni varyantlara kar\u015f\u0131 geli\u015ftirilecek a\u015f\u0131n\u0131n klinik testlerinin ba\u015flad\u0131\u011f\u0131 belirtilirken bu y\u0131l\u0131n sonunda da a\u015f\u0131lar\u0131n sat\u0131\u015fa \u00e7\u0131kaca\u011f\u0131 belirtildi.<\/p>\n<p>\u015eirketin kurucu ortaklar\u0131ndan ve CEO&#8217;su olarak g\u00f6rev yapan U\u011fur \u015eahin, \u015firketin Covid-19 \u00fcr\u00fcn gam\u0131n\u0131 geli\u015ftirdi\u011fi ve ama\u00e7lar\u0131n\u0131n \u201cuzun ve geni\u015f kapsaml\u0131 koruma sa\u011flamak\u201d oldu\u011funu s\u00f6yledi.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/i01.sozcucdn.com\/wp-content\/uploads\/2022\/08\/09\/asi-randevusu-shu.jpg\" alt=\"\" title=\"\"><\/p>\n<p><strong>EK\u0130M AYINI \u0130\u015eARET ETT\u0130LER<\/strong><\/p>\n<p>\u0130ngiliz Financial Times gazetesi, BioNTech&#8217;in Omicron BA.1 varyant\u0131 i\u00e7in ilk a\u015f\u0131 denemelerine ilkbahardan beri ba\u015flad\u0131\u011f\u0131n\u0131 fakat reg\u00fclasyon ve denetleme kurulu\u015flar\u0131 taraf\u0131ndan incelemelerin devam etti\u011fine dikkat \u00e7ekti.<\/p>\n<p>\u015eirket, resmi mercilerden onay al\u0131nmas\u0131 durumunda Omicron BA.4 ve BA.5&#8217;e kar\u015f\u0131 geli\u015ftirilen a\u015f\u0131n\u0131n Ekim ay\u0131nda teslim da\u011f\u0131t\u0131ma \u00e7\u0131kabilece\u011fini duyurdu.<\/p>\n<p><strong>MHRS RANDEVU SAYFASI<\/strong><\/p>\n<p><strong>A\u015eI RANDEVUSU NASIL ALINIR?<\/strong><\/p>\n<p>A\u015f\u0131lama program\u0131 kapsam\u0131nda s\u0131ras\u0131 gelen ve kriterlere uyan vatanda\u015flar, e-Nab\u0131z sistemi \u00fczerinden \u201cCovid-19 a\u015f\u0131 durumunu sorgula\u201d sekmesi alt\u0131ndan bunu kolayl\u0131kla \u00f6\u011frenebilir ya da aralar\u0131nda bo\u015fluk b\u0131rakarak A\u015eI, T.C. Kimlik Numaras\u0131 ve T.C. Kimlik Seri Numaras\u0131n\u0131n son 4 hanesini 2023&#8217;e k\u0131sa mesaj atarak a\u015f\u0131 uygunluk durumlar\u0131n\u0131 \u00f6\u011frenebilirler. Bu a\u015faman\u0131n ard\u0131ndan a\u015f\u0131 onam formuna hem e-Nab\u0131z&#8217;dan hem gelen k\u0131sa mesaj ile eri\u015febiliyor. E\u011fer vatanda\u015f a\u015f\u0131 grubunda yer al\u0131yor ise, a\u015f\u0131 randevusunu; e-Nab\u0131z \u00fczerinden Merkezi Hekim Randevu Sistemine (MHRS) ba\u011flanarak ya da MHRS mobil uygulamalar\u0131n\u0131 kullanarak ve ALO182 hatt\u0131n\u0131 arayarak alabiliyor. T\u00fcm randevu bilgileri hem e-Nab\u0131z&#8217;da hem de vatanda\u015flar\u0131n cep telefonuna gelen k\u0131sa mesajda yer al\u0131yor.<\/p>\n<p><strong>E NABIZ A\u015eI RANDEVUSU EKRANI<\/strong><\/p>\n<p><strong>NE ZAMAN A\u015eI OLACA\u011eIM?<\/strong><\/p>\n<p>E\u011fer \u201cCOVID-19 pandemik a\u015f\u0131lamas\u0131 i\u00e7in belirlenen \u00f6ncelikli grupta de\u011filsiniz. A\u015f\u0131lama i\u00e7in Bakanl\u0131\u011f\u0131m\u0131z\u0131n belirledi\u011fi \u00f6ncelik s\u0131ralamas\u0131 g\u00f6z \u00f6n\u00fcnde bulundurularak durumunuz g\u00fcnl\u00fck de\u011ferlendirmelerle g\u00fcncellenebilecektir. Sa\u011fl\u0131k \u00e7al\u0131\u015fan\u0131 iseniz, \u00e7al\u0131\u015ft\u0131\u011f\u0131n\u0131z kuruma ba\u015fvurarak bilgilerinizin g\u00fcncellenmesini sa\u011flay\u0131n\u0131z.\u201d yaz\u0131s\u0131 yer al\u0131yorsa ise s\u0131ran\u0131z hen\u00fcz gelmemi\u015ftir.<\/p>\n<p><strong>MHRS RANDEVU ALMA<\/strong><\/p>\n<p>Corona a\u015f\u0131s\u0131 i\u00e7in Merkezi Hastane Randevu Sistemi (MHRS) \u00fczerinden https:\/\/www.mhrs.gov.tr\/ veya 182\u2019den randevu al\u0131narak ba\u015fvuru yap\u0131labilecek.<\/p>\n<p>MHRS mobilde randevu almak i\u00e7in ise ak\u0131ll\u0131 cihaz\u0131n\u0131z\u0131n uygulama marketinden MHRS uygulamas\u0131n\u0131 indirerek \u00fcyelik kayd\u0131n\u0131z yoksa olu\u015fturabilir, var ise kimlik numaran\u0131z ve \u015fifreniz ile giri\u015f yaparak randevunuzu alabilirsiniz.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>D\u00fcnya genelinde yayg\u0131n bir varyant haline gelen omicron i\u00e7in Biontech a\u015f\u0131 \u00fcretimine haz\u0131rlan\u0131yor. Omicron BA.4 ve BA.5 gibi yeni Covid-19 &#8230;<\/p>\n","protected":false},"author":1,"featured_media":21394,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[180,2043,2115,1588,1926],"class_list":["post-21393","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-asi","tag-biontech","tag-mhrs","tag-omicron","tag-randevu"],"_links":{"self":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/21393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21393"}],"version-history":[{"count":1,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/21393\/revisions"}],"predecessor-version":[{"id":21395,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/21393\/revisions\/21395"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/media\/21394"}],"wp:attachment":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}